難治性癲癇（1歲以內）全營養配方食品臨床試驗技術指導原則（草案）_Journal of Epilepsy

Authors：

 中國抗癲癇協會生酮飲食專業委員會

執筆郁莉斐^#（復旦大學附屬兒科醫院），方方^#（首都醫科大學附屬北京兒童醫院），鐘建民^#（江西省兒童醫院），李保敏^#（山東大學齊魯醫院），王藝（復旦大學附屬兒科醫院），廖建湘（深圳市兒童醫院），鄧劼（首都醫科大學附屬北京兒童醫院），陳勇（江西省兒童醫院），魏菊榮（深圳市兒童醫院），王娟（重慶醫科大學附屬兒童醫院），于美（深圳市兒童醫院），王紀文（上海交通大學醫學院附屬上海兒童醫學中心），周水珍（復旦大學附屬兒科醫院）;

Corresponding?author：

中國抗癲癇協會生酮飲食專業委員會, Email: wangjiwen@scmc.com.cn

Keywords：

DOI：

10.7507/2096-0247.202403012

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 中國抗癲癇協會生酮飲食專業委員會. 難治性癲癇（1歲以內）全營養配方食品臨床試驗技術指導原則（草案）. Journal of Epilepsy, 2024, 10(3): 206-210. doi: 10.7507/2096-0247.202403012 Copy

1.	中華醫學會兒科學分會神經學組, 中國抗癲癇協會, 中華兒科雜志編輯委員會. 生酮飲食療法在癲癇及相關神經系統疾病中的應用專家共識. 中華兒科雜志, 2019, 57(11): 820-825.
2.	腫瘤全營養配方食品臨床試驗技術指導原則. 腫瘤代謝與營養電子雜志, 2019, 6(4): 427-429.腫瘤全營養配方食品臨床試驗技術指導原則. 腫瘤代謝與營養電子雜志, 2019, 6(4): 427-429.
3.	國家市場監督管理總局規章. 特殊醫學用途配方食品注冊管理辦法. https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/fgs/art/2023/art_9b1a9daffc084d819bb4d7a31d909452.html.
4.	國家市場監督管理總局行政規范性文件. 關于發布特殊醫學用途配方食品臨床試驗質量管理規范(試行)的公告. https://www.samr.gov.cn/zw/zfxxgk/zc/xzgfxwj/art/2020/art_8973ef7fe4db438791cbb7520de7df61.html.
5.	食品藥品監管總局(2016年第48號). 兒科人群藥物臨床試驗技術指導原則. https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20160307164401912.html.
6.	Kwon HE, Kim HD. Recent aspects of ketogenic diet in neurological disorders. Acta Epileptologica, 2021, 21(3): 1-7.
7.	Ye Y, Sun D, Li H, Zhong J, et al. A multicenter retrospective cohort study of ketogenic diet therapy in 481 children with infantile spasms. Acta Epileptologica, 2022, 1(4): 1-8.
8.	Riney K, Bogacz A, Somerville E, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022, 63: 1443-1474.
9.	Zuberi S M, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022, 63: 1349-1397.
10.	Kossoff EH, Zupec Kania BA, Auvin S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open, 2018, 3(2): 175-192.
11.	Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 2015, 56(10): 1515–1523.
12.	Zeng Y, Mu J, Zhou D. Calculation and management of ketogenic diet parenteral nutrition in super-refractory status epilepticus. Acta Epileptologica, 2022, 32(4): 1-9.
13.	Cai M, Xu W, Zheng Y, et al. Ketogenic dietary therapy in adult status epilepticus: current progress and clinical application. Acta Epileptologica, 2022, 16(4): 1-7.
14.	國家藥監局關于發布體外診斷試劑臨床試驗技術指導原則的通告(2021年第72號).(nmpa. gov. cn).
15.	Elles Louw, Dorine Hurk , Elizabeth N, et al. Ketogenic diet guidelines for infants with refractory Epilepsy. European Journal of Paediatric Neurology, 2016, 20(6): 798-809.
16.	Dressler A, Trimmel-Schwahofer P. The ketogenic diet for infants: How long can you go?. Epilepsy Research, 2020, 164(1): 106339.
17.	Falsaperla R, Angelo G, Mauceri L. et al. Ketogenic diet for infants with epilepsy: a literature review. Epilepsy Behav, 2020, 112: 107361.
18.	Schoeler NE, Marston L, Lyons L, et al. Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial. Lancet Neurol, 2023, 22(12): 1113-1124.
19.	Hulst J, Zwart H, Hop W, et al. Dutch national survey to test the STRONGkids nutritional risk screening tool in hospitalized children. Clin Nutr, 2010, 29(1): 106-111.
20.	Engel J. Update on surgical treatment of the epilepsies. Summary of the second international palm desert conference on the surgical treatment of the epilepsies (1992). Neurology, 1993, 43(8): 1612-1617.

1. 中華醫學會兒科學分會神經學組, 中國抗癲癇協會, 中華兒科雜志編輯委員會. 生酮飲食療法在癲癇及相關神經系統疾病中的應用專家共識. 中華兒科雜志, 2019, 57(11): 820-825.
2. 腫瘤全營養配方食品臨床試驗技術指導原則. 腫瘤代謝與營養電子雜志, 2019, 6(4): 427-429.腫瘤全營養配方食品臨床試驗技術指導原則. 腫瘤代謝與營養電子雜志, 2019, 6(4): 427-429.
3. 國家市場監督管理總局規章. 特殊醫學用途配方食品注冊管理辦法. https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/fgs/art/2023/art_9b1a9daffc084d819bb4d7a31d909452.html.
4. 國家市場監督管理總局行政規范性文件. 關于發布特殊醫學用途配方食品臨床試驗質量管理規范(試行)的公告. https://www.samr.gov.cn/zw/zfxxgk/zc/xzgfxwj/art/2020/art_8973ef7fe4db438791cbb7520de7df61.html.
5. 食品藥品監管總局(2016年第48號). 兒科人群藥物臨床試驗技術指導原則. https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20160307164401912.html.
6. Kwon HE, Kim HD. Recent aspects of ketogenic diet in neurological disorders. Acta Epileptologica, 2021, 21(3): 1-7.
7. Ye Y, Sun D, Li H, Zhong J, et al. A multicenter retrospective cohort study of ketogenic diet therapy in 481 children with infantile spasms. Acta Epileptologica, 2022, 1(4): 1-8.
8. Riney K, Bogacz A, Somerville E, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022, 63: 1443-1474.
9. Zuberi S M, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022, 63: 1349-1397.
10. Kossoff EH, Zupec Kania BA, Auvin S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open, 2018, 3(2): 175-192.
11. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 2015, 56(10): 1515–1523.
12. Zeng Y, Mu J, Zhou D. Calculation and management of ketogenic diet parenteral nutrition in super-refractory status epilepticus. Acta Epileptologica, 2022, 32(4): 1-9.
13. Cai M, Xu W, Zheng Y, et al. Ketogenic dietary therapy in adult status epilepticus: current progress and clinical application. Acta Epileptologica, 2022, 16(4): 1-7.
14. 國家藥監局關于發布體外診斷試劑臨床試驗技術指導原則的通告(2021年第72號).(nmpa. gov. cn).
15. Elles Louw, Dorine Hurk , Elizabeth N, et al. Ketogenic diet guidelines for infants with refractory Epilepsy. European Journal of Paediatric Neurology, 2016, 20(6): 798-809.
16. Dressler A, Trimmel-Schwahofer P. The ketogenic diet for infants: How long can you go?. Epilepsy Research, 2020, 164(1): 106339.
17. Falsaperla R, Angelo G, Mauceri L. et al. Ketogenic diet for infants with epilepsy: a literature review. Epilepsy Behav, 2020, 112: 107361.
18. Schoeler NE, Marston L, Lyons L, et al. Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial. Lancet Neurol, 2023, 22(12): 1113-1124.
19. Hulst J, Zwart H, Hop W, et al. Dutch national survey to test the STRONGkids nutritional risk screening tool in hospitalized children. Clin Nutr, 2010, 29(1): 106-111.
20. Engel J. Update on surgical treatment of the epilepsies. Summary of the second international palm desert conference on the surgical treatment of the epilepsies (1992). Neurology, 1993, 43(8): 1612-1617.

Previous Article
癲癇外科手術技術專家共識—第二篇：腦皮質發育不良相關癲癇
Next Article
難治性癲癇（1 ~ 10歲）全營養配方食品臨床試驗技術指導原則（草案）

Journal of Epilepsy

難治性癲癇（1歲以內）全營養配方食品臨床試驗技術指導原則（草案）

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content